By Naveen Pemmaraju, MD;John Mascarenhas, MD;Ruben Mesa, MD;Jeanne M. Palmer, MD;Stephen Oh, MD, PhD
Expert perspectives on the respective treatment landscapes of essential thrombocytopenia (ET) and polycythemia vera (PV) following the ASH 2022 Annual Meeting.